The biopharmaceutical development model incorporates a myriad of opportunities for companies to in-license assets and platforms to augment their drug pipeline. At this time, the conventional and successful model of many face-to-face meetings is impossible, given the COVID-19 pandemic across the world. However, licensing is still an important model and the solution is the virtual licensing meeting. Kineticos has adapted their proven licensing meeting coordination model to this new virtual world.
NOTE: Use your cursor to scroll or the tool-bar located at the bottom to review all available pages.
Licensing Process in a Virtual World
To download the full case study, including example deliverables, click here: Licensing Process in a Virtual World
Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.